Brief: CSL Notes Announcement By United States Administration On 2 April
April 7 (Reuters) - CSL Ltd CSL.AX: NOTES ANNOUNCEMENT BY UNITED STATES ADMINISTRATION ON 2 APRIL INITIAL VIEW IS THAT MOST OF CSL'S U.S. PRODUCT SALES WILL NOT BE SUBJECT TO TARIFFS U.S. ADMINISTRATION HAS RECOGNISED UNIQUE NATURE OF PLASMA-DERIVED THERAPIES UNDER PROCLAMATION EFFECTIVE DATE FOR ANY TARIFF IMPACTS IS 29 SEPTEMBER 2026 Further company coverage: CSL.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CSL
See all newsAustralia's CSL faces investor proceeding over disclosure obligations (updated)
Australia's CSL faces investor proceeding over disclosure obligations
Citi says CSL's CEO pick brings key strengths
Australia's CSL names GSK executive Waterhouse as next CEO (updated)
Brief: CSL Limited Appoints Deborah Waterhouse As CEO And Managing Director